Login / Signup

Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study.

Laurine DiazBenjamin JauzelonAnne-Charlotte DilliesCosette Le SouderJean-Luc FaillieAlexandre Thibault Jacques MariaPascale Palassin
Published in: Journal of clinical medicine (2023)
Clinicians should be aware of the potential risk of ICI-related HLH to improve the early diagnosis of this rare immune-related adverse event.
Keyphrases
  • dna damage
  • adverse drug
  • palliative care
  • cell cycle
  • emergency department
  • oxidative stress
  • risk assessment
  • cell proliferation
  • human health
  • electronic health record